Safety and Efficacy of Early Treatment With Eplerenone in Patients With Acute Myocardial Infarction - REMINDER


The goal of the trial was to evaluate treatment with the mineralocorticoid receptor antagonist eplerenone compared with placebo among patients with ST-segment elevation myocardial infarction (STEMI) without heart failure or significant left ventricular (LV) systolic dysfunction.